Pharmaceutical stability aspects of nanomedicines

Nanomedicine

Volumn 4, Issue 8, 2009, Pages 857-860

  Muthu, Madaswamy S ^a   Feng, Si Shen ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LIPOSOME;

BIOTECHNOLOGICAL PROCEDURES; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; EDITORIAL; ENVIRONMENTAL FACTOR; FREEZE DRYING; HUMAN; HUMIDITY; LIGHT; MOLECULAR STABILITY; NANOMEDICINE; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEMPERATURE; THERMOSTABILITY;

DRUG STABILITY; HUMANS; NANOMEDICINE;

EID: 73349096321     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.75     Document Type: Editorial

References (27)

1. ICH Q1A (R2). Stability testing guidelines: stability testing of new drug substances and products. ICH step 5. CPMP/ICH/2736/99.
2. ICH Q1C. Stability testing for new dosage forms. ICH step 5. CPMP/ICH/280/95.
3. Kreuter J: Nanoparticles as drug delivery systems. Encyclopedia Nanosci. Nanotechnol. 7, 161-180 (2004).
4. Sun B, Feng SS: Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomed. 4, 431-445 (2009).
5. Feng SS: Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert. Rev. Med. Devices 1, 115-125 (2004).
6. Muthu MS, Singh S: Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomed. 4, 105-118 (2009).
7. Muthu MS, Rajesh CV, Mishra A, Singh S: Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomed. 4(6), 657-667 (2009).
8. Muthu MS, Rawat MK, Mishra A, Singh S: PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine 5(3), 323-333 (2009).
9. Muthu MS, Singh S: Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomed. 3, 305-319 (2008).
10. Parveen S, Sahoo SK: Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs. Clin. Pharmacokinet. 45, 965-988 (2006).
11. Vincent MJ, Duncan R: Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 24, 39-47 (2006).
12. ICH Q5C. Stability testing of biotechnological/biological products. ICH step 4. CPMP/ICH/138/95.
13. Muthu MS, Singh S: Poly(D,L-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in vitro evaluation. Curr. Drug Deliv. 6, 62-68 (2009).
14. Ohshima H, Miyagishima A, Kurita T et al.: Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. Int. J. Pharm. 377, 180-184 (2009).
15. Dragicevic-Curic N, Winter S, Krajisnik D et al.: Stability evaluation of temoporfin-loaded liposomal gels for topical application. J. Liposome Res. (2009) (Epub ahead of print).
16. ICH Q1B. Photostability testing of new drug substances and products. ICH step 5. CPMP/ICH/279/95.
17. Lemoine D, Francois C, Kedzierewicz F et al.: Stability study of nanoparticles of poly(ε-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 17, 2191-2197 (1996).
18. Avgoustakis K, Beletsi A, Panagi Z et al.: Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int. J. Pharm. 259, 115-127 (2003).
19. Mulik R, Mahadik K, Paradkar A: Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study. Eur. J. Pharm. Biopharm. 37, 395-404 (2009).
20. Vorauer-Uhl K, Wagner A, Katinger H: Long term stability of rh-Cu/Zn-superoxide dismutase (SOD)-liposomes prepared by the cross-flow injection technique following International Conference on Harmonisation (ICH)-guidelines. Eur. J. Pharm. Biopharm. 54, 83-87 (2002).
21. Alam MN, Ahmad FJ, Sultana Y et al.: Development and characterization of liposome-based formulation of amiloride hydrochloride J. Dispers. Sci. Technol. 29, 415-420 (2008).
22. Watanabe M, Kawano K, Yokoyama M et al.: Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int. J. Pharm. 308, 183-189 (2006).
23. Najlah M, Freeman S, Attwood D, D'Emanuele A: Synthesis, characterization and stability of dendrimer prodrugs. Int. J. Pharm. 308, 175-182 (2006).
24. Xu XQ, Shen H, Xu JR et al.: The colloidal stability and core-shell structure of magnetite nanoparticles coated with alginate. Appl. Surf. Sci. 253, 2158-2164 (2006).
25. Hardwicke J, Ferguson EL, Moseley R et al.: Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair. J. Control. Release 130, 275-283 (2008).
26. Son S, Lee WR, Joung YK et al.: Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles. Int. J. Pharm. 368, 178-185 (2009).
27. Karau C, Petszulat M, Schmidt PC: Preparation and stability of interferon-α-containing liposomes. Int. J. Pharm. 128, 89-98 (1996).